Entyvio (vedolizumab) is an immunosuppressant medication used to treat inflammatory bowel diseases like ulcerative colitis and Crohn's disease [1]. It works by blocking the movement of certain white blood cells, specifically lymphocytes, to the inflamed tissues in the gut [2]. This action reduces inflammation, thereby alleviating symptoms of these conditions [2].
How does Entyvio specifically affect the immune system?
Entyvio targets a specific protein, integrin alpha-4-beta-7 (α4β7), which is found on the surface of lymphocytes [3]. This integrin plays a role in directing immune cells to the gastrointestinal tract [3]. By binding to α4β7, Entyvio prevents these lymphocytes from entering the gut lining, thereby dampening the immune response that contributes to IBD [3]. This mechanism is considered gut-selective, meaning it primarily acts within the digestive system rather than broadly suppressing the entire immune system throughout the body [2][4].
What are the risks of taking Entyvio?
Because Entyvio affects the immune system, individuals taking the medication may be at an increased risk of infections [1]. Patients are advised to inform their doctor if they have an active infection or if they develop signs of infection, such as fever, chills, or a persistent cough [1]. There is also a potential, though rare, risk of certain types of cancers, including skin cancer and progressive multifocal leukoencephalopathy (PML), a serious brain infection [1].
Can Entyvio be used by pregnant or breastfeeding individuals?
For pregnant individuals, Entyvio has been evaluated, and data suggests it may be safe to use during pregnancy [5]. However, it is crucial for pregnant individuals to discuss the risks and benefits with their healthcare provider [5]. Regarding breastfeeding, Entyvio has been detected in human milk, but it is generally considered unlikely to cause harm to a nursing infant [6]. Nevertheless, consultation with a healthcare professional is recommended before breastfeeding while on this medication [6].
What is the outlook for Entyvio patents?
The patent landscape for Entyvio is dynamic. Information regarding patent expirations and exclusivities can be found on resources like DrugPatentWatch.com [7]. Analyzing these patents is crucial for understanding when generic versions of the drug might become available.